Comparison on therapeutic effects of repaglinide with insulin glargine and insulin pump on type 2 diabetes mellitus
Author:
Affiliation:
Fund Project:
摘要
|
图/表
|
访问统计
|
参考文献
|
相似文献
|
引证文献
|
资源附件
|
文章评论
摘要:
目的:探讨甘精胰岛素联合瑞格列奈与胰岛素泵治疗初诊2型糖尿病的疗效。方法:选择60例初诊2型糖尿病,随机分为瑞格列奈联合甘精胰岛素组和胰岛素泵组,根据血糖水平调整用药量。观察两组治疗前后空腹血糖(fasting blood glucose,FBG)、餐后2 h血糖(2-hour postprandial plama glucose,2 h PG)、糖化血红蛋白A1c(glycosylated hemoglobin A1c,HbA1c)和血脂变化情况。结果:治疗后A组和B组患者FBG、2 h PG、HbA1c均较治疗前明显下降(P值A组分别为0.000 3、0.000 1和0.000 2,B组为0.000 4、0.000 2和0.000 2,P<0.05);治疗后A组与B组总甘油三酯(total triglycerides,TG)水平明显降低,总胆固醇(total cholesterol,TC)和低密度脂蛋白-胆固醇(low density lipoprotein-cholesterol,LDL-C)也轻度下降,高密度脂蛋白-胆固醇(high density lipoprotein-cholesterol,LDL-C)轻度升高,组间FBG、2 h PG、HbA1c、TC、TG、HDL-C和LDL-C比较均无统计学差异(P值分别为0.42、0.24、0.35、0.48、0.17、0.54和0.54,P >0.05)。结论:甘精胰岛素联合瑞格列奈是治疗初诊2 型糖尿病患者的理想方案,与胰岛素泵持续皮下输注疗效相当。
Abstract:
Objective:To investigate therapeutic effects of repaglinide with insulin glargine and insulin pump in the treatment of type 2 diabetes mellitus. Methods:Totally 60 patients preliminary diagnosed as type 2 diabetes were randomly divided into two groups. Pa-tients in the two groups respectively accepted repaglinide with insulin glargine therapy and insulin pump therapy. The dosage was ad-justed on the basis of blood glucose level. Changes in fasting blood glucose(FBG),2-hour postprandial plama glucose(2 h PG),rate of glycosylated hemoglobin A1c(HbA1c) and blood lipid of two groups before and after therapy were observed and compared. Results:Levels of FBG,2 h PG and rate of HbAlc were significantly degraded after the therapy(P=0.000 3,0.000 1,0.000 2;P=0.000 4,0.000 2,0.000 2;P<0.05). Levels of total triglyceride(TG),total cholesterol(TC) and low density lipoprotein-cholesterol(LDL-C) were decreased and levels of high density lipoprotein-cholesterol(HDL-C) were increased. There was no statistical difference in FBG,2 h PG,HbA1c,TC,TG,HDL-C and LDL-C between both groups(P=0.42,0.24,0.35,0.48,0.17,0.54,0.54,P >0.05). Conclusions:Repaglin-ide with insulin glargine schedule is an ideally therapy for type 2 diabetes and its curative effect is equivalence to insulin pump.